Rosai–Dorfman disease with MAP2K1 mutation: therapeutic response to MEK inhibition after failure of conventional therapy

Oxford Medical Case Reports · Published 2026-05-27 · DOI 10.1093/omcr/omag079

Free full text

Authors (6)

Carolina Barbosa Carvalho do Carmo, Ana Luiza Potiguara de Sousa, Gabriel Henrique de Souza Alves Glória, Isabella Serpa Andrade Borges, Alesso Cervantes Sartorelli, Alexandre Nonino

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Carmo, C., Sousa, A., Glória, G., et al. (2026). Rosai–Dorfman disease with MAP2K1 mutation: therapeutic response to MEK inhibition after failure of conventional therapy. Oxford Medical Case Reports. https://doi.org/10.1093/omcr/omag079

Related articles